Literature DB >> 9561930

Effect of interleukin-8 and monocyte chemotactic protein-1 on adhesion of circulating granulocytes and monocytes from asthma patients to human venous endothelial cells.

E M Verdegaal1, S T Zegveld, H Beekhuizen, W Bakker, R van Furth.   

Abstract

The adhesive interactions between phagocytes and endothelial cells (EC) can be modulated by inflammatory cytokines and chemotactic proteins which are released during an inflammatory response. The aim of the present study was to investigate first whether the adhesive properties of granulocytes and monocytes from asthma patients for vascular endothelial cells differ from those of phagocytes from healthy individuals. Furthermore, we studied whether the chemokines interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) can affect the binding of phagocytes to EC. No differences were observed in binding of phagocytes from asymptomatic or symptomatic asthma patients and from healthy individuals to non-stimulated or cytokine-stimulated EC. Incubation of granulocytes with IL-8 did not influence their adhesion to non-stimulated EC but inhibited the adhesion of granulocytes to IL-1-stimulated EC. Incubation of monocytes with MCP-1 did not affect their adhesion to non-stimulated or cytokine-stimulated EC. Our results indicate that adhesion of phagocytes to EC depends on the activation state of the endothelial cells but not on the origin of the phagocytes, since there were no differences in the adhesion of phagocytes from asthma patients and healthy individuals to non-stimulated or cytokine-stimulated EC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561930     DOI: 10.1023/a:1022344307926

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  33 in total

1.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Monocyte chemotactic factor produced by large vessel endothelial cells in vitro.

Authors:  J A Berliner; M Territo; L Almada; A Carter; E Shafonsky; A M Fogelman
Journal:  Arteriosclerosis       Date:  1986 May-Jun

Review 3.  Leucocytes in asthma.

Authors:  A B Kay
Journal:  Immunol Invest       Date:  1988 Nov-Dec       Impact factor: 3.657

Review 4.  Endothelial-leukocyte adhesion molecules.

Authors:  M P Bevilacqua
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 5.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

6.  Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

Authors:  M B Lawrence; T A Springer
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

7.  Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes.

Authors:  T Yoshimura; E J Leonard
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

Review 8.  Human monocyte chemoattractant protein-1 (MCP-1).

Authors:  E J Leonard; T Yoshimura
Journal:  Immunol Today       Date:  1990-03

9.  Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions.

Authors:  D Y Leung; J S Pober; R S Cotran
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 10.  Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration.

Authors:  A Rot
Journal:  Immunol Today       Date:  1992-08
View more
  1 in total

1.  Expression of adhesion molecules on granulocytes and monocytes from patients with asthma stimulated in vitro with interleukin-8 and monocyte chemotactic protein-1.

Authors:  E M Verdegaal; S T Zegveld; I Blokland; H Beekhuizen; W Bakker; L N Willems; R van Furth
Journal:  Inflammation       Date:  1998-04       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.